ATARA BIOTHERAPEUTICS, INC. Total Liabilities and Equity
ATARA BIOTHERAPEUTICS, INC. (ATRA) had Total Liabilities and Equity of $21.02 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-12
- 2026-06-30: Liabilities and Equity $21.02M.
- 2026-03-31: Liabilities and Equity $20.00M.
- 2025-12-31: Liabilities and Equity $20.23M.
- 2025-09-30: Liabilities and Equity $30.17M.
| Period end | Liabilities and Equity |
|---|---|
| 2026-06-30 | $21.02M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $20.00M 10-Q · filed 2026-05-12 |
| 2025-12-31 | $20.23M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $30.17M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $36.90M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $62.04M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $109.10M 10-K · filed 2026-03-16 |
| 2024-09-30 | $142.71M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $117.28M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $165.27M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $165.50M 10-K · filed 2025-03-07 |
| 2023-09-30 | $188.79M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $246.44M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $302.08M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $376.42M 10-K · filed 2024-03-28 |
| 2022-09-30 | $368.32M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $436.12M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $397.28M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $468.13M 10-K · filed 2023-02-08 |
| 2021-09-30 | $449.92M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $456.79M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $529.64M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $588.12M 10-K · filed 2022-02-28 |
| 2020-09-30 | $405.53M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $428.11M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $299.55M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $342.94M 10-K · filed 2021-03-01 |
| 2019-09-30 | $364.79M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $274.14M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $324.73M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $391.84M 10-K · filed 2020-02-27 |
| 2018-09-30 | $442.94M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $492.71M 10-Q · filed 2018-08-01 |
| 2018-03-31 | $473.11M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $217.78M 10-K · filed 2019-02-26 |
| 2017-09-30 | $229.69M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $244.16M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $241.74M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $263.91M 10-K · filed 2018-02-27 |
| 2016-09-30 | $284.42M 10-Q · filed 2016-11-04 |
| 2016-06-30 | $300.81M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $312.98M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $324.98M 10-K · filed 2017-03-09 |
| 2015-09-30 | $340.38M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $161.10M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $169.82M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $106.12M 10-K · filed 2016-03-04 |
| 2014-09-30 | $54.12M 10-Q · filed 2014-11-12 |
| 2013-12-31 | $51.83M 10-K · filed 2015-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |